logo-loader
viewNeurotrope

Neurotrope anticipates data from its drug to treat Alzheimer's summer 2019

Neurotrope Inc (NASDAQ:NTRP) CEO Dr. Charles Ryan sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Ryan says the company anticipates data from its drug to treat Alzheimer's summer 2019.

Quick facts: Neurotrope

Price: 1.07 USD

NASDAQ:NTRP
Market: NASDAQ
Market Cap: $13.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Standard Uranium shares details of their project as they...

Standard Uranium (CVE: STND) President and CEO Jon Bey sat down with Steve Darling from Proactive Vancouver to discuss details about uranium exploration company that plan to take public very soon.  Bey telling Proactive about their project in the Athabasca Basin and also abut their...

1 hour, 23 minutes ago

2 min read